Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders
Open accessAbstract
Epigenetic reprogramming of adult human somatic cells to alternative fates, such as the conversion of human skin fibroblasts to induced pluripotency stem cells (iPSC), has enabled the generation of novel cellular models of CNS disorders. Cell reprogramming models appear particularly promising in the context of human neurological disorders of aging such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), for which animal models may not recapitulate key aspects of disease pathology. In addition, recent developments in reprogramming technology have allowed for more selective cell fate interconversion events, as from skin fibroblasts directly to diverse induced neuron (iN) subtypes. Challenges to human reprogramming-based cell models of disease are the heterogeneity of the human population and the extended temporal course of these disorders. A major goal is the accurate modeling of common nonfamilial "sporadic" forms of brain disorders.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuronal differentiation from human NPCs derived from embryonic stem cells or iPSCs recapitulates the in vivo developmental process.
“Neuronal differentiation from human NPCs derived from embryonic stem cells or induced pluripotent stem cells (iPSCs) is able to recapitulate the in vivo developmental process”
From Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation (2016) · cites this paper as Qiang et al., 2013
Cites
2 retracted
Liang, Q., Fujita, R., Yamashita, T., Angulo, S. L., Rhinn, H., Rhee, D. B., Doege, C. A., Chau, L., Aubry, L., Vanti, W. B., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.007 · Cited by 230 · see citing works
RetractedRETRACTED: Efficient Derivation of Functional Floor Plate Tissue from Human Embryonic Stem Cells
Fasano, C. A., Chambers, S. M., Lee, G., Tomishima, M. J., & Studer, L. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.001 · Cited by 210 · see citing works
RetractedTakahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673 · see citing works
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221 · see citing works
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339 · see citing works
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · see citing works
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., & Studer, L. (2009) · Nature Biotechnology · doi:10.1038/nbt.1529 · Cited by 3,620 · see citing works
Direct conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · see citing works
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y.-H., Li, H., Lau, F., Ebina, W., Mandal, P. K., Smith, Z. D., Meissner, A., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.012 · Cited by 2,662 · see citing works
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M., Ji, H., Ehrlich, L., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,429 · see citing works
Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 1× · see citing works
“For instance g-secretase inhibitors, such as semagacestat, are highly effective in transgenic models of AD, but failed in human studies (Karran et al., 2011).”
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061 · see citing works
Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 1,959 · see citing works
Kriks, S., Shim, J., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo‐Reid, L., Auyeung, G., Antonacci, C. L., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,912 · see citing works
Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins
Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814 · see citing works
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441 · see citing works
Modelling schizophrenia using human induced pluripotent stem cells
Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C., Tran, N., Sangar, S., Li, Y., Mu, Y., Chen, G., Yu, D., et al. (2011) · Nature · doi:10.1038/nature09915 · Cited by 1,375 · see citing works
Mazzulli, J. R., Xu, Y.-H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., & Krainc, D. (2011) · Cell · doi:10.1016/j.cell.2011.06.001 · Cited by 1,341 · see citing works
Marchetto, M. C. N., Carromeu, C., Acab, A., Yu, D., Yeo, G. W., Mu, Y., Chen, G., Gage, F. H., & Muotri, A. R. (2010) · Cell · doi:10.1016/j.cell.2010.10.016 · Cited by 1,329 · see citing works
Somatic coding mutations in human induced pluripotent stem cells
Gore, A., Li, Z., Fung, H.-L., Young, J. E., Agarwal, S., Antosiewicz-Bourget, J., Canto, I., Giorgetti, A., Israel, M. A., Kiskinis, E., et al. (2011) · Nature · doi:10.1038/nature09805 · Cited by 1,273 · see citing works
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253 · see citing works
Induction of human neuronal cells by defined transcription factors
Pang, Z. P., Yang, N., Vierbuchen, T., Ostermeier, A., Fuentes, D., Yang, T. Q., Citri, A., Sebastiano, V., Marro, S. G., Südhof, T. C., et al. (2011) · Nature · doi:10.1038/nature10202 · Cited by 1,249 · see citing works
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248 · see citing works
Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons
Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A., Jessell, T. M., Wichterle, H., & Przedborski, S. (2007) · Nature Neuroscience · doi:10.1038/nn1876 · Cited by 1,220 · see citing works
The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167 · see citing works
Genetic engineering of human pluripotent cells using TALE nucleases
Hockemeyer, D. F., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1927 · Cited by 1,129 · see citing works
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,079 · see citing works
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts
Caiazzo, M., Dell’Anno, M. T., Dvoretskova, E., Lazarević, D., Taverna, S., Leo, D., Sotnikova, T. D., Menegon, A., Roncaglia, P., Colciago, G., et al. (2011) · Nature · doi:10.1038/nature10284 · Cited by 1,009 · see citing works
Bock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., Ziller, M., Croft, G. F., Amoroso, M. W., Oakley, D. H., et al. (2011) · Cell · doi:10.1016/j.cell.2010.12.032 · Cited by 1,009 · see citing works
Copy number variation and selection during reprogramming to pluripotency
Hussein, S. M. I., Batada, N., Vuoristo, S., Ching, R., Autio, R., Närvä, E., Ng, S., Sourour, M., Hämäläinen, R., Olsson, C., et al. (2011) · Nature · doi:10.1038/nature09871 · Cited by 992 · see citing works
MicroRNA-mediated conversion of human fibroblasts to neurons
Yoo, A. S., Sun, A. X., Li, L., Shcheglovitov, A., Portmann, T., Li, Y., Lee-Messer, C., Dolmetsch, R. E., Tsien, R. W., & Crabtree, G. R. (2011) · Nature · doi:10.1038/nature10323 · Cited by 919 · see citing works
Laurent, L. C., Ulitsky, I., Slavin, I., Tran, H., Schork, A., Morey, R., Lynch, C., Harness, J. V., Lee, S., Barrero, M. J., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2010.12.003 · Cited by 890 · see citing works
Genetic Animal Models of Parkinson's Disease
Dawson, T. M., Ko, H. S., & Dawson, V. L. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.034 · Cited by 825 · see citing works
Regulation of synaptic connectivity by glia.
Eroglu, C., & Barres, B. A. (2010) · Nature · doi:10.1038/nature09612 · Cited by 813 · cited 1× · see citing works
“For example, Studer and colleagues (Fasano et al., 2010; Kriks et al., 2011) described the efficient production of multipotent neural stem cells with a ventral floor plate phenotype—as defined by a transcription factor expression profile and competence in the generation of several ventral…”
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells
Stadtfeld, M., Apostolou, E., Akutsu, H., Fukuda, A., Follett, P., Natesan, S., Kono, T., Shioda, T., & Hochedlinger, K. (2010) · Nature · doi:10.1038/nature09017 · Cited by 801 · see citing works
Non–cell autonomous effect of glia on motor neurons in an embryonic stem cell–based ALS model
Di Giorgio, F. P., Carrasco, M. A., Siao, M. C., Maniatis, T., & Eggan, K. (2007) · Nature Neuroscience · doi:10.1038/nn1885 · Cited by 799 · see citing works
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B. J., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, J. W., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.01.013 · Cited by 748 · see citing works
Kondo, T., Asai, M., Tsukita, K., Kutoku, Y., Ohsawa, Y., Sunada, Y., Imamura, K., Egawa, N., Yahata, N., Okita, K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.01.009 · Cited by 741 · see citing works
Direct conversion of human fibroblasts to dopaminergic neurons
Pfisterer, U., Kirkeby, A., Torper, O., Wood, J. C., Nelander, J., Dufour, A., Björklund, A., Lindvall, O., Jakobsson, J., & Parmar, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105135108 · Cited by 740 · see citing works
Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells
Yamanaka, S. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.012 · Cited by 737 · see citing works
Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728 · see citing works
Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., Lundblad, M., Lindvall, O., & Parmar, M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.009 · Cited by 662 · see citing works
Mash1regulates neurogenesis in the ventral telencephalon
Casarosa, S., Schuurmans, C. J., & Guillemot, F. (1999) · Development · doi:10.1242/dev.126.3.525 · Cited by 639 · see citing works
Basic helix-loop-helix factors in cortical development.
Ross, S. E., Greenberg, M., & Stiles, C. (2003) · Neuron · doi:10.1016/s0896-6273(03)00365-9 · Cited by 637 · see citing works
Neural induction, the default model and embryonic stem cells
Muñoz-Sanjuán, I., & Brivanlou, A. H. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn786 · Cited by 635 · see citing works
Conversion of Mouse and Human Fibroblasts into Functional Spinal Motor Neurons
Son, E., Ichida, J. K., Wainger, B. J., Toma, J. S., Rafuse, V. F., Woolf, C. J., & Eggan, K. C. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.07.014 · Cited by 629 · see citing works
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615 · see citing works
Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., Huo, H., Loh, Y., Aryee, M. J., Lensch, M. W., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.2052 · Cited by 613 · see citing works
Chambers, S. M., Qi, Y., Mica, Y., Lee, G., Zhang, X., Niu, L., Bilsland, J., Cao, L., Stevens, E. B., Whiting, P. J., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2249 · Cited by 605 · see citing works
Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., Takada, N., Inoue, M., Hasegawa, M., Kawamata, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103509108 · Cited by 604 · see citing works
Modeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599 · see citing works
Kang, S. H., Li, Y., Fukaya, M., Lorenzini, I., Cleveland, D. W., Ostrow, L. W., Rothstein, J. D., & Bergles, D. E. (2013) · Nature Neuroscience · doi:10.1038/nn.3357 · Cited by 599 · see citing works
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome
Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., Cord, B., Palmer, T. D., Chikahisa, S., Nishino, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2576 · Cited by 585 · see citing works
Direct reprogramming of mouse fibroblasts to neural progenitors
Kim, J., Efe, J. A., Zhu, S., Talantova, M. V., Xu, Y., Wang, S., Lipton, S. A., Zhang, K., & Ding, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103113108 · Cited by 568 · see citing works
Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits
Xue, Y., Ouyang, K., Huang, J., Zhou, Y., Ouyang, H., Li, H., Wang, G., Wu, Q., Wei, C., Bi, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2012.11.045 · Cited by 562 · see citing works
Sánchez‐Danés, A., Richaud‐Patín, Y., Carballo‐Carbajal, I., Jiménez‐Delgado, S., Caig, C., Mora, S., Guglielmo, C. D., Ezquerra, M., Patel, B., Giralt, A., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200215 · Cited by 557 · see citing works
Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors.
Nieto, M., Schuurmans, C., Britz, O., & Guillemot, F. (2001) · Neuron · doi:10.1016/s0896-6273(01)00214-8 · Cited by 553 · see citing works
Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells
Egawa, N., Kitaoka, S., Tsukita, K., Naitoh, M., Takahashi, K., Yamamoto, T., Adachi, F., Kondo, T., Okita, K., Asaka, I., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004052 · Cited by 552 · see citing works
Ring, K. L., Tong, L. M., Balestra, M. E., Javier, R., Andrews-Zwilling, Y. S., Li, G., Walker, D., Zhang, W. R., Kreitzer, A. C., & Huang, Y. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.05.018 · Cited by 540 · see citing works
Lee, G., Kim, H., Elkabetz, Y., Al-Shamy, G., Panagiotakos, G., Barberi, T., Tabar, V. S., & Studer, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1365 · Cited by 527 · see citing works
Direct Reprogramming of Fibroblasts into Neural Stem Cells by Defined Factors
Han, D., Tàpia, N., Hermann, A., Hemmer, K., Höing, S., Araúzo-Bravo, M. J., Zaehres, H., Wu, G., Frank, S., Moritz, S., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.02.021 · Cited by 514 · see citing works
Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508 · see citing works
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Ding, Q., Lee, Y., Schaefer, E. A. K., Peters, D., Veres, A., Kim, K. J., Kuperwasser, N., Motola, D., Meissner, T. B., Hendriks, W. T. J., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.11.011 · Cited by 501 · see citing works
Reinhardt, P., Schmid, B., Burbulla, L. F., Schöndorf, D. C., Wagner, L., Glatza, M., Höing, S., Hargus, G., Heck, S. A., Dhingra, A., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.01.008 · Cited by 500 · see citing works
Koch, P., Opitz, T., Steinbeck, J. A., Ladewig, J., & Brüstle, O. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808387106 · Cited by 491 · see citing works
A functionally characterized test set of human induced pluripotent stem cells
Boulting, G. L., Kiskinis, E., Croft, G. F., Amoroso, M. W., Oakley, D. H., Wainger, B. J., Williams, D. J., Kahler, D. J., Yamaki, M., Davidow, L. S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1783 · Cited by 489 · see citing works
Giorgio, F. P. D., Boulting, G. L., Bobrowicz, S., & Eggan, K. C. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.09.017 · Cited by 488 · see citing works
Direct Conversion of Fibroblasts into Stably Expandable Neural Stem Cells
Thier, M. C., Wörsdörfer, P., Lakes, Y. B., Gorris, R., Herms, S., Opitz, T., Seiferling, D., Quandel, T., Hoffmann, P., Nöthen, M. M., et al. (2012) · Cell stem cell · doi:10.1016/j.stem.2012.03.003 · Cited by 485 · see citing works
Direct Reprogramming of Adult Human Fibroblasts to Functional Neurons under Defined Conditions
Ambasudhan, R., Talantova, M. V., Coleman, R., Xu, Y., Zhu, S., Lipton, S. A., & Ding, S. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.07.002 · Cited by 480 · see citing works
Presenilins and -Secretase: Structure, Function, and Role in Alzheimer DiseasePreprint
Strooper, B. D., Iwatsubo, T., & Wolfe, M. S. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006304 · Cited by 465 · see citing works
Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease
Lobsiger, C. S., & Cleveland, D. W. (2007) · Nature Neuroscience · doi:10.1038/nn1988 · Cited by 438 · see citing works
Parras, C., Schuurmans, C., Scardigli, R., Kim, J., Anderson, D. J., & Guillemot, F. (2002) · Genes & Development · doi:10.1101/gad.940902 · Cited by 434 · see citing works
Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells
Lujan, E., Chanda, S., Ahlenius, H., Südhof, T. C., & Wernig, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121003109 · Cited by 421 · see citing works
Genetic Correction of Huntington’s Disease Phenotypes in Induced Pluripotent Stem Cells
An, M., Zhang, N.-Z., Scott, G., Montoro, D. T., Wittkop, T., Mooney, S., Melov, S., & Ellerby, L. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.04.026 · Cited by 385 · see citing works
Seibler, P., Graziotto, J. J., Jeong, H., Šimunović, F., Klein, C., & Krainc, D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4441-10.2011 · Cited by 375 · see citing works
Li, W., Sun, W., Zhang, Y., Wei, W., Ambasudhan, R., Xia, P., Talantova, M. V., Lin, T., Kim, J., Wang, X., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014041108 · Cited by 375 · see citing works
The Seeds of Neurodegeneration: Prion-like Spreading in ALS
Polymenidou, M., & Cleveland, D. W. (2011) · Cell · doi:10.1016/j.cell.2011.10.011 · Cited by 370 · see citing works
Role for glia in synaptogenesis
Ullian, E. M., Christopherson, K. S., & Barres, B. A. (2004) · Glia · doi:10.1002/glia.20082 · Cited by 370 · see citing works
Understanding the role of TDP-43 and FUS/TLS in ALS and beyond
Da Cruz, S., & Cleveland, D. W. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.05.029 · Cited by 351 · see citing works
Serio, A., Bilican, B., Barmada, S. J., Ando, D. M., Zhao, C., Siller, R., Burr, K., Haghi, G., Story, D., Nishimura, A. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1300398110 · Cited by 345 · see citing works
Direct Lineage Conversion of Terminally Differentiated Hepatocytes to Functional Neurons
Marro, S. G., Pang, Z. P., Yang, N., Tsai, M.-C., Qu, K., Chang, H. Y., Südhof, T. C., & Wernig, M. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.09.002 · Cited by 343 · see citing works
Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells
Lafaille, F. G., Pessach, I. M., Zhang, S., Ciancanelli, M. J., Casadio, M., Abhyankar, A., Ying, S., Keros, S., Goldstein, P. A., Mostoslavsky, G., et al. (2012) · Nature · doi:10.1038/nature11583 · Cited by 341 · see citing works
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W., et al. (2012) · Nature · doi:10.1038/nature11557 · Cited by 339 · see citing works
Bilican, B., Serio, A., Barmada, S. J., Nishimura, A. L., Sullivan, G. J., Carrasco, M., Phatnani, H. P., Puddifoot, C. A., Story, D., Fletcher, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202922109 · Cited by 328 · see citing works
Genetic insights in Alzheimer's disease
Bettens, K., Sleegers, K., & Broeckhoven, C. V. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70259-4 · Cited by 326 · see citing works
Small molecules enable highly efficient neuronal conversion of human fibroblasts.
Ladewig, J., Mertens, J., Kesavan, J., Doerr, J., Poppe, D., Glaue, F., Herms, S., Wernet, P., Kögler, G., Müller, F.-J., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1972 · Cited by 316 · see citing works
Byers, B., Cord, B. J., Nguyen, H. N., Schüle, B., Fenno, L. E., Lee, P. C., Deisseroth, K. A., Langston, J. W., Pera, R. A. R., & Palmer, T. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026159 · Cited by 295 · see citing works
Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
Pimplikar, S. W., Nixon, R. A., Robakis, N. K. R. K., Shen, J., & Tsai, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4305-10.2010 · Cited by 281 · see citing works
Stadtfeld, M., Apostolou, E., Ferrari, F., Choi, J., Walsh, R. M., Chen, T., Ooi, S. K. T., Kim, S. Y., Bestor, T. H., Shioda, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.1110 · Cited by 281 · see citing works
Regulatory logic of neuronal diversity: Terminal selector genes and selector motifs
Hobert, O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806070105 · Cited by 280 · see citing works
Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells
Zhang, N.-Z., An, M., Montoro, D. T., & Ellerby, L. (2010) · PLOS Currents · doi:10.1371/currents.rrn1193 · Cited by 266 · see citing works
Functional Integration of Dopaminergic Neurons Directly Converted from Mouse Fibroblasts
Kim, J., Su, S. C., Wang, H., Cheng, A. W., Cassady, J. P., Lodato, M. A., Lengner, C. J., Chung, C. Y., Dawlaty, M. M., Tsai, L., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.09.011 · Cited by 257 · see citing works
Jiang, H., Ren, Y., Yuen, E. Y., Zhong, P., Ghaedi, M., Hu, Z., Azabdaftari, G., Nakaso, K., Yan, Z., & Feng, J. (2012) · Nature Communications · doi:10.1038/ncomms1669 · Cited by 254 · see citing works
Accelerated High-Yield Generation of Limb-Innervating Motor Neurons from Human Stem Cells
Amoroso, M. W., Croft, G. F., Williams, D. J., O’Keeffe, S., Carrasco, M. A., Davis, A. R., Roybon, L., Oakley, D. H., Maniatis, T., Henderson, C. E., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0906-12.2013 · Cited by 244 · see citing works
Rakovic, A., Shurkewitsch, K., Seibler, P., Grünewald, A., Zanon, A., Hagenah, J., Krainc, D., & Klein, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391680 · Cited by 218 · see citing works
Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome
Kim, K., Hysolli, E., & Park, I. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018979108 · Cited by 212 · see citing works
Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo
Rouaux, C., & Arlotta, P. (2013) · Nature Cell Biology · doi:10.1038/ncb2660 · Cited by 205 · see citing works
Corti, S. P., Nizzardo, M., Simone, C., Falcone, M., Nardini, M., Ronchi, D., Donadoni, C., Salani, S., Riboldi, G. M., Magri, F., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004108 · Cited by 205 · see citing works
Direct Conversion of C. elegans Germ Cells into Specific Neuron Types
Tursun, B., Patel, T., Kratsios, P., & Hobert, O. (2010) · Science · doi:10.1126/science.1199082 · Cited by 203 · see citing works
Directed differentiation of human pluripotent cells to neural crest stem cells
Menéndez, L., Kulik, M. J., Page, A. T., Park, S. S., Lauderdale, J. D., Cunningham, M. L., & Dalton, S. (2013) · Nature Protocols · doi:10.1038/nprot.2012.156 · Cited by 200 · see citing works
Zeng, H., Guo, M., Martins‐Taylor, K., Wang, X., Zhang, Z., Park, J. W., Zhan, S., Kronenberg, M. S., Lichtler, A. C., Liu, H.-X., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011853 · Cited by 196 · see citing works
Yahata, N., Asai, M., Kitaoka, S., Takahashi, K., Asaka, I., Hioki, H., Kaneko, T., Maruyama, K., Saido, T. C., Nakahata, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025788 · Cited by 175 · see citing works
Lo, L., Dormand, E., Greenwood, A. L., & Anderson, D. J. (2002) · Development · doi:10.1242/dev.129.7.1553 · Cited by 158 · see citing works
Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology
Rhinn, H., Qiang, L., Yamashita, T., Rhee, D. B., Zolin, A., Vanti, W. B., & Abeliovich, A. (2012) · Nature Communications · doi:10.1038/ncomms2032 · Cited by 142 · see citing works
Specification of neuronal and glial subtypes from human pluripotent stem cells
Liu, H., & Zhang, S. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0770-y · Cited by 142 · see citing works
FGF signalling inhibits neural induction in human embryonic stem cells
Greber, B., Coulon, P., Zhang, M., Moritz, S., Frank, S., Müller-Molina, A. J., Araúzo-Bravo, M. J., Han, D., Pape, H., & Schöler, H. R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.407 · Cited by 142 · see citing works
Measurement of the t -Channel Single Top Quark Production Cross Section in pp Collisions at s=7 TeV
Chatrchyan, S., Khachatryan, V., Sirunyan, A. M., Tumasyan, A., Adam, W., Bergauer, T., Dragicevic, M., Erö, J., Fabjan, C. W., Friedl, M., et al. (2011) · Physical Review Letters · doi:10.1103/physrevlett.107.091802 · Cited by 131 · see citing works
Almeida, S., Zhang, Z., Coppola, G., Mao, W., Futai, K., Karydas, A., Geschwind, M. D., Tartaglia, M. C., Gao, F., Gianni, D., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.007 · Cited by 129 · see citing works
Revisiting oxidative damage in ALS: microglia, Nox, and mutant SOD1
Boillée, S., & Cleveland, D. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34613 · Cited by 95 · see citing works
Wang, F., Yin, Y., Ye, X., Liu, K., Zhu, H., Wang, L., Chiourea, M., Okuka, M., Ji, G., Dan, J., et al. (2011) · Cell Research · doi:10.1038/cr.2011.201 · Cited by 95 · see citing works
Modeling Timothy syndrome with iPS cells
Yazawa, M., & Dolmetsch, R. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9444-x · Cited by 58 · see citing works
Generation of Human-Induced Pluripotent Stem Cells to Model Spinocerebellar Ataxia Type 2 In vitro
Xia, G., Santostefano, K. E., Hamazaki, T., Liu, J., Subramony, S. H., Terada, N., & Ashizawa, T. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9930-2 · Cited by 57 · see citing works
Schnitzler, A. C., Mellott, T. J., López-Coviella, I., Tallini, Y. N., Kotlikoff, M. I., Follettie, M. T., & Blusztajn, J. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5611-09.2010 · Cited by 47 · see citing works
Reprogramming Therapeutics: iPS Cell Prospects for Neurodegenerative Disease
Abeliovich, A., & Doege, C. A. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.024 · Cited by 40 · see citing works
Modelling familial dysautonomia in human induced pluripotent stem cells
Lee, G., & Studer, L. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0026 · Cited by 37 · see citing works
Shimada, T., Takai, Y., Shinohara, K., Yamasaki, A., Tominaga‐Yoshino, K., Ogura, A., Toi, A., Asano, K., Shintani, N., Hayata‐Takano, A., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07724.x · Cited by 22 · see citing works
Search for Pair Production of Second-Generation Scalar Leptoquarks in pp Collisions at s=7 TeV
Khachatryan, V., Sirunyan, A. M., Tumasyan, A., Adam, W., Bergauer, T., Dragicevic, M., Erö, J., Fabjan, C. W., Friedl, M., Fruhwirth, R. K., et al. (2011) · Physical Review Letters · doi:10.1103/physrevlett.106.201803 · Cited by 20 · see citing works
Acute reduction in oxygen tension enhances the induction of neurons from human fibroblasts
Davila, J., Chanda, S., Ang, C. E., Südhof, T. C., & Wernig, M. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.03.020 · Cited by 19 · see citing works
Cell transplantation for spinal cord injury focusing on iPSCs
Nakamura, M., Tsuji, O., Nori, S., Toyama, Y., & Okano, H. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.681774 · Cited by 16 · see citing works
Epigenetic Regulation of Pluripotency
Tomazou, E. M., & Meissner, A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-7037-4_3 · Cited by 8 · see citing works
Flagged first, then by citations
2 of the 123 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
How neuroinflammation contributes to neurodegeneration
Ransohoff, R. M. (2016) · Science · doi:10.1126/science.aag2590 · Cited by 1,967 · see citing works
Zheng, X., Boyer, L., Jin, M., Mertens, J., Kim, Y., Ma, L., Ma, L., Hamm, M., Gage, F. H., & Hunter, T. (2016) · eLife · doi:10.7554/elife.13374 · Cited by 671 · see citing works
“Neuronal differentiation from human NPCs derived from embryonic stem cells or induced pluripotent stem cells (iPSCs) is able to recapitulate the in vivo developmental process and has been successfully used to model a variety of neurological diseases (Qiang et al., 2013).”
BackgroundiPS cells: a game changer for future medicine
Inoue, H., Nagata, N., Kurokawa, H., & Yamanaka, S. (2014) · The EMBO Journal · doi:10.1002/embj.201387098 · Cited by 403 · see citing works
“…i.e. direct reprogramming, which can be used to induce specific types of cells, including neurons (Vierbuchen, et al, 2010; Son et al, 2011; Qiang et al, 2013), cardiomyocytes (Ieda et al, 2010), blood cell progenitors (Szabo et al, 2010), hepatocyte-like cells (Huang et al, 2011; Sekiya &…”
BackgroundModeling pain in vitro using nociceptor neurons reprogrammed from fibroblasts
Wainger, B. J., Buttermore, E. D., Oliveira, J. T., Mellin, C., Lee, S., Saber, W. A., Wang, A. J., Ichida, J. K., Chiu, I. M., Barrett, L. B., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3886 · Cited by 207 · see citing works
Epigenetic therapy for F riedreich ataxia
Soragni, E., Miao, W., Iudicello, M., Jacoby, D. B., Mercanti, S. F. D., Clerico, M., Longo, F., Piga, A., Ku, S., Campau, E., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24260 · Cited by 156 · see citing works
“This approach can potentially be used to test other therapeutics for FRDA and for neurological disorders in general.(37) Furthermore, because we assayed cellular responses at a relatively early stage of neuronal differentiation, we are able to exploit the mitotically active nature of differentiated neural stem cells a…”
BackgroundZheng, X., Boyer, L. F., Jin, M., Kim, Y., Fan, W., Bardy, C., Berggren, W. T., Evans, R. M., Gage, F. H., & Hunter, T. R. (2016) · eLife · doi:10.7554/elife.13378 · Cited by 137 · see citing works
“The effect of rapamycin on cellular ATP level was examined in neurons derived from human embryonic stem cells, an approach that has been successfully used to model a variety of neurological diseases (Qiang et al., 2013).”
Human-induced pluripotent stem cells: potential for neurodegenerative diseases
Ross, C. A., & Akimov, S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu204 · Cited by 109 · see citing works
“There have been several recent reviews of the application of iPSCs to neurodegenerative disease research (3,5,18,39,40).”
BackgroundHandel, A. E., Chintawar, S., Lalic, T., Whiteley, E. S., Vowles, J., Giustacchini, A., Argoud, K., Sopp, P., Nakanishi, M., Bowden, R. J., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddv637 · Cited by 104 · see citing works
“Cortical neurons derived from iPSCs using suchmethods have been used to study a wide variety of neurodevelopmental and neurodegenerative conditions, and recapitulate disease-relevant phenotypes (1).”
BackgroundEndoplasmic Reticulum Stress: Relevance and Therapeutics in Central Nervous System Diseases
Zhang, H., Wang, Z., Lu, X., Kong, X., Wu, F., Li, L., Tan, X., Ye, L.-B., & Xiao, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8813-7 · Cited by 92 · see citing works
“Amyotrophic lateral sclerosis (ALS) is a chronic progressive degenerative disease that affects not only the upper motor neurons (in the brain, brainstem, and spinal cord) but also the lower motor neurons (the cranial nerve nuclei and anterior horn cells) that control the muscles of the trunk, limbs, head, and face [55…”
BackgroundRaitano, S., Ordovás, L., Muynck, L. D., Guo, W., Espuny-Camacho, I., Geraerts, M., Khurana, S., Vanuytsel, K., Tóth, B. I., Voets, T., et al. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.12.001 · Cited by 82 · see citing works
“4 j 16–24 j January 13, 2015 j a2015 The Author generative diseases (Qiang et al., 2013) and, specifically, FTD (Almeida et al.”
BackgroundPistollato, F., Ohayon, E. L., Lam, A., Langley, G. R., Novak, T. J., Pamies, D., Perry, G. L., Trushina, E. V., Williams, R. S. B., Roher, A. E., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9175 · Cited by 78 · see citing works
“Possible strategies to overcome this limitation might be to directly reprogram fibroblasts into nervous system cell types [69, 70] or, in order to retain the epigenetic background of neuronal cells, to reprogram post-mitotic neurons into iPSCs [71].”
BackgroundHofrichter, M., Nimtz, L., Tigges, J., Kabiri, Y., Schröter, F., Royer‐Pokora, B., Hildebrandt, B., Schmuck, M. R., Epanchintsev, A., Theiss, S., et al. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.10.013 · Cited by 74 · see citing works
Kim, T. P., Yea, C., Chueng, S. D., Yin, P. T., Conley, B., Dardir, K., Pak, Y., Jung, G. Y., Choi, J., & Lee, K. (2015) · Advanced Materials · doi:10.1002/adma.201502489 · Cited by 74 · see citing works
The effects of the TOMM40 poly‐T alleles on Alzheimer's disease phenotypes
Chiba‐Falek, O., Gottschalk, W. K., & Lutz, M. W. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.015 · Cited by 59 · see citing works
“Human-induced pluripotent stem cells– derived brain cell types represent a powerful tool to model in vitro molecular and cellular aspects of human neurodegenerative diseases including LOAD and enable deeper exploration of key molecular mechanisms underlying the disease in pathology-relevant neuronal/glia cell types ot…”
BackgroundiPSC technology-Powerful hand for disease modeling and therapeutic screen
Kim, C. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.5.100 · Cited by 57 · see citing works
“org BMB Reports broblast to neurons have been reported recently (75).”
BackgroundSynthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons
Xue, Y., Zhan, X., Sun, S., Karuppagounder, S. S., Xia, S., Dawson, V. L., Dawson, T. M., Laterra, J., Zhang, J., & Ying, M. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0036 · Cited by 53 · see citing works
Sagal, J., Zhan, X., Xu, J., Tilghman, J. I., Karuppagounder, S. S., Chen, L., Dawson, V. L., Dawson, T. M., Laterra, J., & Ying, M. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0213 · Cited by 46 · see citing works
Wnt1-regulated genetic networks in midbrain dopaminergic neuron development
Wurst, W., & Prakash, N. (2013) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjt046 · Cited by 48 · see citing works
“…U niversitaet M uenchen user on 05 August 2019 more specifically the SNc DA neuronal subset either in vitro in the culture dish by the directed differentiation of pluripotent stem cells, or in situ by the direct conversion (reprogramming) of somatic cells into these neurons (Qiang et al., 2013).”
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00510-y · Cited by 43 · see citing works
Wang, J., Shamah, S. M., Sun, A. X., Waldman, I. D., Haggarty, S. J., & Perlis, R. H. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.72 · Cited by 41 · see citing works
Glia–neuron interactions in neurological diseases: Testing non-cell autonomy in a dish
Meyer, K., & Kaspar, B. K. (2016) · Brain Research · doi:10.1016/j.brainres.2015.12.051 · Cited by 36 · see citing works
“…fibroblasts from skin biopsies of patients or endothelial cells from urine samples can be recovered and reprogrammed into induced pluripotent stem cells (iPSCs) and then differentiated into various cell types (Juopperi, 2012; Qiang et al., 2013; Czepiel, 2011; Emdad et al., 2012; Hester, 2011).”
Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
Tousley, A. R., & Kegel-Gleason, K. B. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160199 · Cited by 37 · see citing works
“However, the potential for off-target effects due to random viral insertions motivated scientists to develop novel non-integrating approaches for delivery including Sendai-virus [29], adenovirus [30] and episomal vectors [6, 31], as well as RNA transfection [32], protein [33], and small molecule [34, 35] based methods…”
BackgroundPatient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
Tang, S., Xie, M., Cao, N., & Ding, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00789 · Cited by 35 · see citing works
Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases
Cao, L., Tan, L., Jiang, T., Zhu, X., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8867-6 · Cited by 35 · see citing works
“Even though this review focuses on AD, PD, HD and ALS, many other patients can benefit from this technology [31].”
Metabo-Devo: A metabolic perspective of development
Gándara, L., & Wappner, P. (2018) · Mechanisms of Development · doi:10.1016/j.mod.2018.02.004 · Cited by 31 · see citing works
Multiplication of theSNCAlocus exacerbates neuronal nuclear aging
Tagliafierro, L., Zamora, M. E., & Chiba‐Falek, O. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy355 · Cited by 29 · see citing works
“two markers of peripheral heterochromatin: (1) HP1γ and (2)”
RETRACTED ARTICLE: Senescence impairs direct conversion of human somatic cells to neurons
Sun, C., Zhou, D., Zhang, Z., He, L., Zhang, F., Wang, X., Yuan, J., Chen, Q., Wu, L., & Yang, Q. (2014) · Nature Communications · doi:10.1038/ncomms5112 · Cited by 28 · see citing works
RetractedMassa, M., Gisevius, B., Hirschberg, S., Hinz, L., Schmidt, M., Gold, R., Prochnow, N., & Haghikia, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155274 · Cited by 22 · see citing works
“Because there is evidence of both genomic stability [15,22,23] and epigenetic persistence [24] through the procedure of iPSC conversion and differentiation, the cell- and patient-specific in vitro paradigmmay not only contain relevant genetic material, but also epigenetic information necessary for the investigation of…”
BackgroundEpigenetic Research of Neurodegenerative Disorders Using Patient iPSC‐Based Models
Fernández‐Santiago, R., & Ezquerra, M. (2015) · Stem Cells International · doi:10.1155/2016/9464591 · Cited by 23 · see citing works
Orack, J. C., Deleidi, M., Pitt, D., Mahajan, K. R., Nicholas, J. A., Boster, A. L., Racke, M. K., Comabella, M., Watanabe, F., & Imitola, J. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0133 · Cited by 23 · see citing works
Nano-Biosensor for Monitoring the Neural Differentiation of Stem Cells
Lee, J., Lee, T., & Choi, J. (2016) · Nanomaterials · doi:10.3390/nano6120224 · Cited by 23 · see citing works
“Specifically, accurately monitoring cell differentiation is extremely important in treating devastating neural diseases, including Parkinson’s disease (PD), Alzheimer’s disease and spinal cord injuries [11].”
Backgroundhling, T. M. ⁄., Duda, J., Weishaupt, J. H., Ludolph, A. C., & Liss, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00353 · Cited by 21 · see citing works
“Either SOD1G93A hMNs might dedifferentiate or reprogram their neuronal phenotype due to the disease process, as described for other cell types (Sarthy et al., 1991; Hol et al., 2003; Arendt, 2008; Puri and Hebrok, 2012; Qiang et al., 2013; Gao et al., 2014), and due to this process co-express GFAP.”
BackgroundA Human-Based Integrated Framework forAlzheimer’s Disease Research
Pistollato, F., Cavanaugh, S. E., & Chandrasekera, P. C. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150281 · Cited by 21 · see citing works
“, neurons) available only postmortem, short periods of tissues and cells time in culture AD patient-derived hiPSCs and Accounting for patient heterogeneity, [97–102] further differentiation into neurons recapitulating common features of AD, applicable for drug evaluations, suitable for high-throughput assays AD patien…”
Lin, L., Liu, A., Li, H., Feng, J., & Yan, Z. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190190 · Cited by 18 · see citing works
“However, the heterogeneity of the human population, the extended temporal course of the disease, and the accurate modeling of common non-familial “sporadic” forms of AD remain challenges for human reprogramming-based cell models [17].”
BackgroundNeuroregeneration: Regulation in Neurodegenerative Diseases and Aging
Бобкова, Н. В., Полтавцева, Р. А., Leonov, S. V., & Sukhikh, G. T. (2020) · Biochemistry (Moscow) · doi:10.1134/s0006297920140060 · Cited by 17 · see citing works
“There are still challenges associated with the models of different neurodegenerative disorders based on human reprogrammed cells [282], including the genetic diversity of these disorders and of the human pop ulation.”
BackgroundSolving the puzzle of Parkinson’s disease using induced pluripotent stem cells
Zhao, P., Luo, Z., Tian, W., Yang, J., Ibañez, D. P., Huang, Z., Tortorella, M. D., Esteban, M. A., & Fan, W. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538588 · Cited by 16 · see citing works
“An attractive alternative is to complement research on PD using neural cells produced by means of somatic cells transdifferentiation.(75,76,79) The latter has the advantage that the procedure is quicker, and the costs are smaller, thus allowing simultaneous manipulation of many samples.”
BackgroundCharacterization of Genetic Networks Associated with Alzheimer’s Disease
Zhang, B., Tran, L. M., Emilsson, V., & Zhu, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2627-5_28 · Cited by 14 · see citing works
Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling
Grzybek, M., Golonko, A., Walczak, M., & Lisowski, P. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.11.007 · Cited by 12 · see citing works
Doege, C. A., & Abeliovich, A. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.01.007 · Cited by 11 · see citing works
Li, J., Zhang, F., Yu, L., Fujimoto, N., Yoshioka, M., Li, X., Shi, J., Kotera, H., Liu, L., & Chen, Y. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb02246d · Cited by 10 · see citing works
Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168
Glenn, O.-C., Tagliafierro, L., Beach, T. G., Woltjer, R. L., & Chiba‐Falek, O. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00133 · Cited by 10 · see citing works
“However, other non-genetic factors such as, aging presumably modify epigenetic states and can influence gene regulation (Qiang et al., 2013; Doege and Abeliovich, 2014).”
BackgroundCell therapy for neurological disorders: The elusive goal
Tandon, P., & Seth, P. (2016) · Neurology India · doi:10.4103/0028-3886.185418 · Cited by 10 · see citing works
Kumar, D., & Hassan, M. I. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.11.040 · Cited by 9 · see citing works
Gibson, G. E., & Thakkar, A. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.06.007 · Cited by 8 · see citing works
Wenker, S. D., Casalia, M. L., Candedo, V. C., Casabona, J. C., & Pitossi, F. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.023 · Cited by 7 · see citing works
“from PSCs was has already been achieved by several research groups [90,16,35,61,8,42,58].”
BackgroundInfluentialBelle, K. C., Shabazz, F. S., Nuytemans, K., Davis, D. A., Ali, A., Young, J. L., Scott, W. K., Mash, D. C., Vance, J. M., & Dykxhoorn, D. M. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.065 · Cited by 7 · see citing works
Roles of Epigenetics in the Neural Stem Cell and Neuron
Yamamoto, N., Uesaka, M., Imamura, T., & Nakashima, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417114-5.00004-8 · Cited by 6 · see citing works
Bauer, P. O., Dunmore, J., Sasaguri, H., & Maťoška, V. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00935 · Cited by 6 · see citing works
Live Imaging of Primary Neurons in Long-Term Cryopreserved Human Nerve Tissue
Fortea, M., Jain, P., Demedts, I., Tack, J. F., Vanuytsel, T., Cirillo, C., & Berghe, P. V. (2021) · eNeuro · doi:10.1523/eneuro.0388-21.2021 · Cited by 3 · see citing works
“Despite the great innovation introduced by this approach, crucial aspects need to be considered: (1) fibroblasts need to be artificially manipulated through at least (or alternatively) two steps before becoming neurons; (2) the success rate of neuronal generation is quite low (Qiang et al., 2013); and (3) neurons ofte…”
BackgroundInduced Pluripotent Stem Cells as a Cell-Based Therapeutic in Stroke
Hess, D. C., Fakhri, N., & West, F. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-15063-5_9 · Cited by 1 · see citing works
“, motor or dopaminergic neurons) [9, 10].”
Novel Insights into the Mechanisms of Regulation of Tyrosine Kinase Receptors by Ras Interference 1
Galvis, A. (2014) · doi:10.25148/etd.fi14040866
“....................................................... 80 V. DISCUSSION ................................................................................................. 99 FUTURE WORK ............................................................................................... 106 MATERIALS AND METHODS ...........…”
BackgroundInfluentialStem cells in Parkinson’s disease: an updatePreprint
Gollamudi, S. (2016) · doi:10.15200/winn.148233.37308
Chou, H., Mao, X., & Ying, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822277-5.00003-1
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132532
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132544
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132541
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132535
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132538
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132529
Li, Q., Feng, Y., Xue, Y., Zhan, X., Fu, Y., Gui, G., Zhou, W., Richard, J., Taga, A., Li, P. P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.18132550
Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1
“Des protocoles déjà établis par plusieurs équipes permettent maintenant de différencier des iPSC en plusieurs types neuronaux (dopaminergiques, cholinergiques, glutamatergiques, GABAergiques, sérotoninergiques) (voir Qiang et al., 2013).”
BackgroundLanfranchi, M. (2021) · theses.fr (ABES) · doi:10.70675/247335b1zba7fz4005zafbdzdc43c088d75f
- Authors
- Qiang, L., Fujita, R., & Abeliovich, A.
- Affiliations
- Columbia University (US)
- Corresponding author
- Abeliovich, Asa
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 78
- Issue
- 6
- Pages
- 957-969
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W1970762906
- Cited by
- 59
- References
- 123
- Citations by year
- 2022: 4 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 14 · 2015: 10 · 2014: 15 · 2013: 1
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 383 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- somatic cell reprogramming, induced pluripotent stem cells, induced neurons, cellular disease model, neurodegeneration, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, aging, dermal fibroblasts, epigenetic reprogramming, disease heterogeneity
- MeSH terms
- Adult, Animals, Disease Models, Animal, Fibroblasts, Humans, Neurodegenerative Diseases, Induced Pluripotent Stem Cells, Neural Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review